Profile for Humoral and Cellular Immunity and Cachexia
Usage Recommendation
For those who want to test their Immune System
Use of the Exam
The Immune-Frame uses cell-specific markers and production of Cytokines to detect the type or types of cells that are responsible for activating or repressing a patient's immune system.
Two different tests are used to export the result. The ELISA assay is used for the detection of cytokines produced by specific cells in the serum sample. On the other hand, flow cytometry is used for the enumeration of specific markers in peripheral blood cells.
Both assays are then compared to a control sample and the results are plotted as the following table:
Natural Substances (ONCONOMICS EXTRACTS)
This test can identify more effective Natural Substances for the treatment of Tumor Cells and Cancer Stem Cells and increase the function of the Immune System.
Many of the substances tested support the immune system by reducing the number of cancer cells through the process of "Angiogenesis" or "Apoptosis".
The selection of tested Natural Substances follows with a base of Clinical Study and Scientific Evidence of each substance and its anti-cancer property. In addition, it is well documented that many natural agents are used in the development of drugs in the binding of the structure or in the design of drugs, including various chemotherapeutics.
In summary, this test provides information on:
The development of cachexia.
The presence or absence of dendritic cells (DCs) and whether they are stimulated
Type of CANCER
All Types of Cancer
"Except for the Cabeca and Central Nervous System"
Type of SAMPLE
Peripheral Blood Normal (20 to 30ml)
RESULT Time
10 to 14 working days
Kit COLLECTION
RGCC provides the necessary collection kit with detailed instructions for sample collection and logistics, upon request
Information Provided Against Cancer Cells:
The development of humoral and cell-specific immunity
The presence of immunosuppressive mechanism (T-regs)
Non-specific cellular immunity